Home › GlaxoSmithKline opts to hold on to HIV business
 

Keywords :   


GlaxoSmithKline opts to hold on to HIV business

2015-05-06 15:04:10| Biotech - Topix.net

British-based drugmaker GlaxoSmithKline has opted to keep its stand-alone HIV business as it set out its strategy following the completion of its recent deal with Switzerland's Novartis. GSK said it has cancelled an initial public offering of its HIV business, ViiV Healthcare, opting instead to retain its full holding in the joint venture with equity partners Pfizer and Shiongi.

Tags: business hold hiv glaxosmithkline

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
More »